Miraca Holdings is a holding company mainly engaged in the manufacture and sale of clinical reagents for agglutination and serology testing. Co. is engaged in the development, manufacture and sale of in vitro diagnostic reagents, including test reagents and testing devices mainly in the fields of infectious and oncological diseases to medical institutions and commercial laboratories; and the provision of all-round laboratory testing services, including general testing and esoteric testing, clinical trial-related services to support pharmaceutical research and development, as well as sterilization-outsourcing services of reusable medical and surgical instruments.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.